RU95113020A - METHOD FOR TREATING ENDOMETRIOSIS - Google Patents

METHOD FOR TREATING ENDOMETRIOSIS

Info

Publication number
RU95113020A
RU95113020A RU95113020/14A RU95113020A RU95113020A RU 95113020 A RU95113020 A RU 95113020A RU 95113020/14 A RU95113020/14 A RU 95113020/14A RU 95113020 A RU95113020 A RU 95113020A RU 95113020 A RU95113020 A RU 95113020A
Authority
RU
Russia
Prior art keywords
treating endometriosis
carotene
beta
endometriosis
treating
Prior art date
Application number
RU95113020/14A
Other languages
Russian (ru)
Other versions
RU2108757C1 (en
Inventor
А.А. Чиркин
Н.П. Поддубный
Р.В. Казарян
С.П. Кудинова
Original Assignee
Акционерное общество "РОСКАРФАРМ"
Filing date
Publication date
Application filed by Акционерное общество "РОСКАРФАРМ" filed Critical Акционерное общество "РОСКАРФАРМ"
Priority to RU95113020A priority Critical patent/RU2108757C1/en
Priority claimed from RU95113020A external-priority patent/RU2108757C1/en
Publication of RU95113020A publication Critical patent/RU95113020A/en
Application granted granted Critical
Publication of RU2108757C1 publication Critical patent/RU2108757C1/en

Links

Claims (2)

1. Способ лечения эндометриоза, включающий лазеротерапию, отличающийся тем, что больному в качестве лечебного препарата назначают бета-каротин из расчета 40 - 45 мг/сут в виде пищевой добавки "Каролин".1. A method of treating endometriosis, including laser therapy, characterized in that the patient is prescribed beta-carotene at the rate of 40 - 45 mg / day as a dietary supplement "Caroline" as a therapeutic drug. 2. Способ по п. 1, отличающийся тем, что срок введения бета-каротина составляет не менее 14 дней. 2. The method according to p. 1, characterized in that the period of administration of beta-carotene is at least 14 days.
RU95113020A 1995-07-26 1995-07-26 Method of endometritis treatment RU2108757C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU95113020A RU2108757C1 (en) 1995-07-26 1995-07-26 Method of endometritis treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95113020A RU2108757C1 (en) 1995-07-26 1995-07-26 Method of endometritis treatment

Publications (2)

Publication Number Publication Date
RU95113020A true RU95113020A (en) 1997-07-20
RU2108757C1 RU2108757C1 (en) 1998-04-20

Family

ID=20170575

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95113020A RU2108757C1 (en) 1995-07-26 1995-07-26 Method of endometritis treatment

Country Status (1)

Country Link
RU (1) RU2108757C1 (en)

Similar Documents

Publication Publication Date Title
ZA924772B (en) Delayed therapy
IS1858B (en) Method of producing a pharmaceutical composition in the form of pellets for the treatment of intestinal inflammation
NO964864L (en) Oral liquid alendronate preparations
BG104476A (en) Therapeutical form for tolterodin with controlled release
HUP0004583A2 (en) A method for producing medicin containing liposomal encapsulated taxane
RO116342B1 (en) Oral liquid pharmaceutical composition
CA2264852A1 (en) Use of methylphenidate or a pharmaceutically acceptable salt thereof
GR3034186T3 (en) 3,4-diarylchromans for treatment of dermatitis
DK0668077T3 (en) Products containing G-CSF and TNF-binding protein
NO20003313D0 (en) Therapeutic agents
MY124465A (en) Reduction of infarct volume using citicoline
WO2000057867A3 (en) Improved cancer treatment with temozolomide
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
RU95113020A (en) METHOD FOR TREATING ENDOMETRIOSIS
GR3025372T3 (en) Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patients
MY114716A (en) Prophylactic and/or therapeutic treatment of dyspeptic symptoms
EP0803256A4 (en) Drug for relieving side effects caused by immunosuppressants
RU96113328A (en) METHOD OF BRAKING FIBER FORMATION
UA30654A (en) Method for treatment of posttraumatic disfunctions of temporomandibular joint
KR930019207A (en) Use of L-carnitine for the treatment of carnitine deficient HIV-serum positive patients
RU93016030A (en) A MEDICINE STIMULATING THE GRANULOSITARY GROWTH OF HEMATOPHONYA IN CYTOSTATIC MYELODEPRESSIONS
RU96104214A (en) METHOD FOR TREATING TRANSSUDATIVE FORMS OF CENTRAL CHORIORETHINAL DYSTROPHIES
MD1469G2 (en) Method of treatment of the burn shock
UA28644A (en) Method of the treatment of a primary amenorrhea of the central genesis in the girls-teenagers
UA29005A (en) The method for treatment of low extremities trophic ulcers